Clinical Chemistry







Simple Method Monitors β-Cell Death in Type 1 Diabetes Individuals
The β-cell killing that characterizes type 1 diabetes is thought to begin years before patients present clinically with metabolic decompensation; however, this primary pathologic process of the disease has not been measured. More...17 Feb 2015
In Other News
Protein Saliva Test Diagnoses Autism
Proteins Likely to Trigger Psoriasis Identified
Four New Biomarkers Identified for Cardiovascular Risk
Robust Method Determines Serum Chromium and Cobalt
Diagnostic Assay and Handheld Analyzers Exhibited in Dubai
Gold Nanoparticles Indicate Early Detection of Heart Attacks
Enzyme Assay on Impregnated Filter Paper Detects Krabbe Disease
Bioengineers Present Glucose Monitor Tattoo Prototype
Blood Test Aids Diagnosis of Appendicitis
Blood Test Measures Hepatic Fibrosis Progression
New Robotic Solution Enhances Workflow Within Compact Footprint
Heart Failure Patients’ Blood Glucose Levels Predict Mortality Risk
Sensitive Estrogen Detection Method Developed
Fecal Occult Blood Screening Increases High-Risk Polyp Detection
Blood Test Approved That Predicts Coronary Heart Disease Risk
Novel Biomarkers Identified for Incident Coronary Heart Disease
Zinc Isotope Test Helps Detect Early Breast Cancer
Whole Cell Glycated Hemoglobin Control Calibrated for Most Popular Instruments
Urine Test Ensures Asthmatic Children Receive Appropriate Treatment
Cardiovascular Risk Predicted by Test Measuring HDL Proteins
Simple Breath Test Aids Type 1 Diabetes Early Diagnosis
Improved Assay Determines d-Xylose in Urine and Serum
Cholesterol Levels in Later Life Depend in Part on Apolipoprotein E Allele Status
The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.




 Assay.jpg)



